Company profile: Dynasty Diagnostics
1.1 - Company Overview
Company description
- Provider of customized solutions to traditional toxicological testing for healthcare professionals and providers.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Dynasty Diagnostics
Desert Tox
HQ: United States
Website
- Description: Provider of SAMHSA-certified laboratory testing services, offering workplace forensic drug and alcohol testing; DOT and non-DOT services (pre-employment, reasonable suspicion, return to duty, random, post-accident, follow-up); customizable panels; DOT-approved alcohol testing by certified technicians; and support for drug-free workplace programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Desert Tox company profile →
Pathline Labs
HQ: United States
Website
- Description: Provider of sub-specialized anatomic pathology services for hospitals and physician laboratories, offering comprehensive lab services; hematopathology testing (next-generation sequencing, flow cytometry, molecular); oncology pathology for cancer diagnosis, treatment and monitoring with rapid turnaround and consultative services; histology processing with digital slide imaging; dermatopathology; and customized hospital pathology partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pathline Labs company profile →
StrataDx
HQ: United States
Website
- Description: Provider of anatomic pathology laboratory services for physicians, patients, and hospitals, with board-certified pathologists. Offerings include dermatopathology, oral pathology, alopecia evaluation using horizontal sections, DermSTAT Skin Infection PCR assays (including nail PCR with terbinafine resistance detection), in-house IHC, DIF, ISH and special stains, and clinical research support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StrataDx company profile →
Interim Diagnostic Imaging
HQ: United States
Website
- Description: Provider of mobile medical imaging and procedural solutions, renting Mobile MRI, CT, and trailer-housed PET scanners and Mobile Cardiac Cath Labs for short- and long-term interim needs, collaborating to guide selection of appropriate, cost-effective technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interim Diagnostic Imaging company profile →
The Derm Lab
HQ: United States
Website
- Description: Provider of accurate and timely diagnostic interpretation of biopsies of skin diseases and tumors, with expertise in clinicopathologic correlation. Offers phone and picture consultations to more accurately diagnose challenging cases and can assist with treatment plans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full The Derm Lab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Dynasty Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Dynasty Diagnostics
2.2 - Growth funds investing in similar companies to Dynasty Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Dynasty Diagnostics
4.2 - Public trading comparable groups for Dynasty Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →